Intellia Phase 1/2 Clinical Trial Authorized for Hereditary Angioedema Treatment

https://ir.intelliatx.com/news-releases/news-release-details/intellia-therapeutics-receives-authorization-initiate-phase-12
JOIN OUR MAILING LIST

 

 
 
 
 

IPIRA is committed to meeting the needs of people with disabilities in a timely manner by preventing and removing barriers to accessibility. We also adhere to the UC Berkeley policy on nondiscrimination, and protect the privacy of confidential information.